Motoi Tobiume

Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: Comparative study of immunohistochemistry and fluorescent in situ hybridization

Hiroyuki Matsubara, Yoshiaki Yamada, Katsuya Naruse et al. · Oncology Reports · 2008 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +14

Penetration of piperacillin–tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics

Ikuo Kobayashi, Kazuro Ikawa, Kogenta Nakamura et al. · Journal of Infection and Chemotherapy · 2015 · 21 citations

Medicine, Pharmacokinetics, Pharmacology +9

Lactate dehydrogenase is a prognostic indicator for prostate cancer patients with bone metastasis.

Katsuya Naruse, Yoshiaki Yamada, Shigeyuki Aoki et al. · PubMed · 2007 · 21 citations · Full text

Medicine, Oncology, Bone Metabolism +16

Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer

Shigeyuki Aoki, Yoshiaki Yamada, Kogenta Nakamura et al. · Oncology Reports · 2006 · 17 citations · Full text

Medicine, Molecular Biology, Oncology +14

An immunohistochemical study of chromogranin A and human epidermal growth factor‐2 expression using initial prostate biopsy specimens from patients with bone metastatic prostate cancer

Yoshiaki Yamada, Kogenta Nakamura, Shigeyuki Aoki et al. · British Journal of Urology · 2006 · 13 citations · Full text

Medicine, Oncology, Pathology +17